|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 207/456 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| C07D 401/04 | (2006.01) | ||
| C07K 16/32 | (2013.01) | ||
| C07K 16/32 | (2006.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61K 47/68 | (2017.01) | ||
| C07D 207/456 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 401/04 | (2013.01) | ||
| A61K 47/6889 | (2017.08) | ||
| A61K 47/6849 | (2017.08) | ||
| A61K 47/6851 | (2017.08) | ||
| Y02P 20/55 | (2015.11) | ||
| A61K 47/68031 | (2023.08) | ||
| A61K 47/68033 | (2023.08) |
| (11) | Number of the document | 3868409 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19900942.4 |
| Date of filing the European patent application | 2019-12-13 | |
| (97) | Date of publication of the European application | 2021-08-25 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2019/124982 |
| Date | 2019-12-13 |
| (87) | Number | WO 2020/125546 |
| Date | 2020-06-25 |
| (30) | Number | Date | Country code |
| 201811541356 | 2018-12-17 | CN |
| (72) |
HUANG, Changjiang , CN
YE, Hui , CN
CHEN, Hu , CN
ZHAN, Xiuzhi , CN
SHEN, Nan , CN
LUO, Wenting , CN
HOU, Qiaohua , CN
FANG, Jianmin , CN
|
| (73) |
RemeGen Co., Ltd. ,
China (Shandong) Pilot Free Trade Zone
Yantai District, Yantai Development Zone
No.58 Beijing Middle Road, Shandong 264006,
CN
|
| (54) | THIOPHENOL-MALEIMIDE AND BROM-MALEIMIDE DERIVATIVES AS LINKER FOR ANTIBODY-DRUG CONJUGATES (ADC) FOR TREATING TUMORS |
| THIOPHENOL-MALEIMIDE AND BROM-MALEIMIDE DERIVATIVES AS LINKER FOR ANTIBODY-DRUG CONJUGATES (ADC) FOR TREATING TUMORS |